{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-26-004392","form_type":"8-K","ticker":"GOVX","cik":"0000832489","company_name":"GeoVax Labs, Inc.","filed_at":"2026-02-17T23:59:59+00:00","discovered_at":"2026-05-14T18:02:37.798906+00:00","generated_at":"2026-05-16T02:39:37.795266+00:00","sec_items":["1.01","3.02","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"GeoVax raises ~$1M gross in registered direct offering priced at $2.31/share","bullets":["Offering of 432,902 shares (or pre-funded warrants) at $2.31/share; net proceeds ~$865,000.","Concurrent private placement of Series A-1 and A-2 warrants for up to 432,902 shares each, exercisable at $2.31 after shareholder approval.","Existing warrants for 236,000 shares amended: exercise price reduced from $4.35 to $2.31, subject to shareholder approval.","Proceeds to fund R&D, manufacturing, clinical studies, and working capital.","H.C. Wainwright acted as sole placement agent; closing occurred February 17, 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-26-004392","json":"https://secwatch.observer/filing/0001437749-26-004392.json","markdown":"https://secwatch.observer/filing/0001437749-26-004392.md","text":"https://secwatch.observer/filing/0001437749-26-004392.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/832489/000143774926004392/0001437749-26-004392-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/832489/000143774926004392/govx20260217_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T02:39:37.795266+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"93535fc8f652962a294a95c45b5ab487a481df1b","claim":"GeoVax Labs, Inc. entered into Purchase Agreement with the purchasers party thereto valued at approximately $865,000 (effective 2026-02-13).","evidence_excerpt":"On February 13, 2026, GeoVax Labs, Inc. (the “Company”) entered into a securities purchase agreement (the “Purchase Agreement”) with the purchasers party thereto, pursuant to which the Company agreed to issue and sell, in a registered direct offering (the “Offering”), an aggregate of (i) 402,000 shares (the “Shares”) of the Company’s common stock, $0.001 par value per share (the “Common Stock”) and (ii) pre-funded warrants (the “Pre-Funded Warrants”) to purchase up to an aggregate of 30,902 shares of Common Stock (the “Pre-Funded Warrant Shares”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/832489/000143774926004392/0001437749-26-004392-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"the purchasers party thereto"},{"label":"Value","value":"approximately $865,000"},{"label":"Effective","value":"2026-02-13"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}